Yinghong Wang

Efficacy and Safety of Infliximab for Management of Immune-Related Adverse Events: A Retrospective Analysis

Immune-related adverse events (irAEs) are common complications of immune checkpoint inhibitor (ICI) therapy and frequently require immunosuppressive treatment. Infliximab is commonly used for steroid-refractory irAEs; however, the optimal dosing strategy remains unclear. The stud...